Leukaemia of the myeloid series in patients with Hodgkin's disease.
Explore the source record for details and available documents.
Adolescent↗
Biomedical subjects
W Sizoo
Publications and source records attributed to W Sizoo.
Ciprofloxacin and norfloxacin for selective decontamination in patients with severe granulocytopenia.
In a randomized multicenter study, ciprofloxacin and norfloxacin, each in two different dose regimens and in combination with non-absorbable antimycotics, were administered to 51 patients with acute leukaemia undergoing aggressive remission induction chemotherapy for infection prevention. Both drugs showed an effective elimination of gram-negative potential pathogens and Staphylococcus aureus not affecting the anaerobic flora of the gastrointestinal tract. A low incidence of side effects and a satisfactory patient compliance could be observed. A daily dosage of 1,000 mg ciprofloxacin or 800 mg norfloxacin is recommended for infection prevention in severely granulocytopenic patients.
Acute Disease↗